Stem cells broke into the public consciousness in the early 1990s, alluring for their potential to help the body beat back diseases of degeneration Alzheimer’s, and to grow new parts to treat conditions like spinal cord injuries.
Progress has been slow. The Michael J. Fox Foundation for Parkinson’s Research, an early supporter of stem cell research, pulled its financial backing two years ago, saying that it preferred to invest in research that was closer to providing immediate help for Parkinson’s disease patients.
But researchers have been slowly learning how to best use stem cells, what types to use and how to deliver them to the body — findings that are not singularly transformational, but progressive and pragmatic.
Read the full story at New York Times.